Riskpilot← Back to searchSign inGet full accessMed-Oliver Oy
OYActiveY-tunnus 1611230-6Wäinönkuja 4-AMedical specialists activities · NACE 8622Est. 20001 employees
Revenue 2024
EUR 568K
-1% vs 2023
EBITDA margin
18.9%
-41% vs 2023
Equity ratio
68.1%
Financial strength
Net profit 2024
EUR 67K
-47% vs 2023
| Revenue | EUR 568K | -1% |
| EBITDA | EUR 108K | -41% |
| Net profit | EUR 67K | -47% |
| Total assets | EUR 1,3M | -6% |
| Equity | EUR 910K | -3% |
| Employees | 1 | — |
Legal name
Med-Oliver Oy
Y-tunnus number
1611230-6
Legal form
Osakeyhtiö
NACE code
8622 · Medical specialists activities
Founded
6. huhtikuuta 2000
Share capital
EUR 8 409
Employees
1 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Hallituksen jäsenet ja toimitusjohtaja kukin yksin
Company purpose
Yhtiön toimialana on myydä yleislääkärin, yleiskirurgian ja ortopedian lääkäri-, konsultaatio- ja kuntoutuspalveluja sekä työterveyteen ja vakuutuslääketieteeseen kuuluvia palveluja ja lääketieteellisiä tutkimuspalveluja. Yhtiö voi tuottaa, kustantaa ja myydä lääketieteellistä kirjallisuutta sekä antaa alan koulutusta. Se voi omistaa, vuokrata ja myydä huoneistoja. Se voi harjoittaa arvopaperikauppaa. Yhtiö voi myös vuokrata ja myydä tai palkata sairaanhoito-, terveydenhoito-, perushoito- tai lastenhoito-henkilökuntaa. Yhtiö voi myös maahantuoda ja jälleenmyydä alan tarvikkeita.
Address
Wäinönkuja 4-A
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 499 | 473 | 454 | 573 | 568 |
| Staff expenses | −164 | −161 | −205 | −228 | −301 |
| EBITDA | 200 | 188 | 138 | 184 | 108 |
| Depreciation & amort. | −6 | −4 | −15 | −12 | −9 |
| EBIT | 194 | 183 | 123 | 172 | 99 |
| Net financials | −2 | −0 | −4 | −14 | −20 |
| Profit before tax | 192 | 183 | 118 | 157 | 78 |
| Tax | 39 | 37 | 24 | 29 | 11 |
| Net profit | 154 | 146 | 94 | 128 | 67 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 985 | 1 278 | 1 378 | 1 419 | 1 337 |
| Equity | 841 | 920 | 915 | 943 | 910 |
| Long-term debt | — | — | 412 | 400 | 393 |
| Short-term debt | 144 | 357 | 51 | 76 | 34 |
| Total debt | 144 | 357 | 463 | 476 | 427 |
EBITDA margin
18.9%
This company
15.8%
Market median
+20% vs market
20202024
Equity ratio
68.1%
This company
38.2%
Market median
+78% vs market
20202024
Return on equity
7.4%
This company
18.4%
Market median
-60% vs market
20202024
Net profit margin
11.9%
This company
8.1%
Market median
+47% vs market
20202024
Asset turnover
0.42×
This company
1.12×
Market median
-63% vs market
20202024
Debt / equity
0.47×
This company
0.62×
Market median
+24% vs market
20202024
- Annual report 2024Filed via PRH / YTJ · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via PRH / YTJ · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via PRH / YTJ · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via PRH / YTJ · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via PRH / YTJ · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
HO Chief Executive Officer | Chief Executive Officer | 2005 |
| Former (2) | ||
EO Audit | Audit | 2000 – 2022 |
GA Deputy auditor | Deputy auditor | 2000 – 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Board of Directors | 2005 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Med-Oliver Oy also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Eero Olavi Heikkilä | Audit | 0 companies |
| Henrik Oliver Michelsson | Chief Executive Officer | 0 companies |
| Gunnel Astrid Heikkilä | Deputy auditor | 0 companies |
| Riikka Kristina Michelsson | Board of Directors | 0 companies |